The engine of sustainable growth: mastering nurture and transition for V28 margin expansion

Editor's note: This is the third installment in a series on turning the post-V28 landscape into a growth opportunity. Part 1 outlined the financial shift. Part 2 focused on precision acquisition and early retention. This final piece addresses what sustains performance: long-term engagement and internal transition strategies that convert clinical complexity into lasting margin.

The first 90 days are only the beginning

The first 90 days matter. Enroll the right members. Capture risk accurately. Establish early engagement.

But that’s not the finish line—it’s the starting point.

Sustainable margin expansion under V28 depends on what happens next: sustained member support and proactive management of rising clinical complexity. For care management and population health leaders, the real financial leverage lies in what happens between visits, not at enrollment.

Nurture turns early insight into long-term performance

In our previous blog, The clinical-growth coalition: a Medicare Advantage blueprint for maximizing margin, we covered the mechanics of early engagement: automating Health Risk Assessments (HRAs), honoring preferred communication channels, and closing initial care gaps. Those are table stakes.

What separates leading plans is what they build on top of that foundation.

The HRA identifies where a member starts. Nurture is the system that moves members forward through personalized outreach, dynamic segmentation, and interventions that evolve with their condition.

For members managing multiple comorbidities, effective nurture requires layered, condition-specific content that accounts for how chronic conditions interact. It also requires smarter workload distribution: using engagement data to identify in real time which members are disengaging or declining, so high-touch intervention is directed where it will have the greatest clinical and financial impact.

Done right, nurture transforms chronic condition management from a reactive cost center into a proactive driver of adherence, lower utilization, and long-term retention. To realize this transformation, plans should focus on a few core strategic shifts that translate activity into measurable impact.

Engagement alone doesn’t drive performance

Engagement, on its own, is not the goal. Impact is. Many programs successfully drive clicks, calls, and completed tasks. Far fewer translate that activity into measurable clinical or financial outcomes.

High-performing plans close this gap by aligning engagement strategies directly to performance metrics: medication adherence, gap closure, and condition control. Outreach is not just frequent. It is purposeful, timed to clinical need, and designed to influence specific behaviors.

Star Ratings decide who gets paid — and who doesn’t

Star Ratings are often framed as quality metrics. In practice, they are a direct revenue lever.

Measures tied to chronic disease management and medication adherence carry the greatest weight. Plans that consistently close care gaps and drive adherence don’t just improve outcomes; they materially increase reimbursement.

The difference is significant. Crossing the 4-star threshold unlocks Quality Bonus Program payments, with lower-performing plans effectively leaving revenue on the table.

Higher ratings do not require net-new programs. They require existing programs designed to influence the measures that matter most consistently over time.

Integrate behavioral health or absorb the cost

Behavioral health is not adjacent to chronic disease management. It is foundational to it.

Depression and other behavioral health conditions are strongly correlated with poor adherence across core conditions like diabetes, hypertension, and hyperlipidemia—all key Star measures. When unaddressed, they compound risk, increase utilization, and suppress performance.

Leading plans treat behavioral health as an integrated component of chronic care, not a parallel workstream. This includes proactive screening, coordinated outreach, and embedded referral pathways that reduce friction for both members and providers.

This is not a wellness initiative. It is core to performance.

Reward outcomes, not activity

Traditional engagement programs reward participation: completed assessments, answered calls, and opened messages. But activity does not equal impact. A more effective model ties incentives (both member-facing and programmatic) to clinical milestones: adherence thresholds, completed follow-up visits, or sustained condition control. These behaviors directly influence utilization and cost. 

This approach creates a clear line between engagement investment and financial return. It shifts the focus from volume of interaction to value of outcome.

The biggest care gaps happen outside the exam room

The highest risk—and the greatest opportunity—exists between clinical encounters. Without visibility into what happens outside the exam room, providers operate with incomplete information. Missed medications, delayed follow-ups, and unaddressed symptoms accumulate quietly until they result in higher-cost interventions.

Integrating engagement data into provider workflows closes this gap. When providers can see what members are doing between visits, care becomes more consistent and coordinated. Plans can respond in real time as needs change.

This creates a continuous loop of insight and action, improving adherence, reducing redundancy, and strengthening both outcomes and documentation.

Transition: the most efficient growth comes from within

Not all growth requires acquisition. As members age and conditions progress, many become eligible for specialized plans such as C-SNPs, D-SNPs, or I-SNPs. When those transitions are missed, plans absorb increasing costs without corresponding reimbursement.

Internal transitions are among the most efficient forms of growth: no acquisition cost and minimal competitive friction. It is revenue hiding inside the existing member population, waiting for the operational precision to surface it.

Identify eligibility before it becomes urgent

Successful transitions depend on early identification. Eligibility signals such as rising acuity, increased utilization, new diagnoses, or changes in eligibility status, should be continuously monitored, not surfaced through periodic review. Acting early ensures members are aligned with the right plan before costs escalate.

Even earlier action can be initiated by monitoring engagement data, which captures clinical complexity signals in real time. The same engagement infrastructure that supports a member's chronic condition journey can also identify when that journey has outgrown the plan they're in and trigger a transition review before cost escalation makes it urgent.

This requires treating transitions as a coordinated population strategy, not isolated product decisions.

Execution speed determines financial impact

Identification creates opportunity. Execution captures it. Manual workflows introduce delays, compliance risk, and missed reimbursement opportunities. Each delay directly impacts time to reimbursement and total realized value.

Automation changes the equation, streamlining eligibility verification, documentation, and enrollment into a coordinated, scalable process. As interoperability standards like FHIR mature, this level of execution will become baseline. Plans investing now will be positioned to move faster and capture disproportionate value.

Transitions succeed or fail with the member experience

Transitions are operationally complex. But for members, they should feel simple and supportive. 

Poor communication creates confusion and churn risk, especially among high-acuity populations. Effective transitions position the change as an upgrade in care, not an administrative shift. Clarity, timing, and channel matter. Done well, transitions strengthen trust and retention. Done poorly, they erode both.

Provider alignment is the difference between intent and action

Provider alignment is not optional. It is a prerequisite. Incomplete or inconsistent documentation delays transitions, introduces compliance risk, and limits reimbursement accuracy. Even well-designed transition strategies fail without provider participation.

Leading plans address this by embedding education, prompts, and documentation support directly into provider workflows, making the right action the easy action.

This is not a downstream step. It is foundational to ensuring transitions are clinically appropriate and financially realized.

Final thought 

In the post-V28 environment, growth and margin are inseparable from clinical strategy.

The model is unified: Identify the right members. Engage them early. Sustain adherence over time. Transition complexity into the right plans.

Plans that execute across all four dimensions will define the next era of Medicare Advantage. Every clinical interaction becomes both a care decision and a financial one.